Positive:
- Launching the center of excellence in Genomics
- Implementing the CRM, will help in efficient, automated business process to increase productivity.
- Rajasthan bid is big one and can give 200-300 crore revenue per year. Waiting for result.
Negative:
- Recent IT raid
- Management is not walking the talk. 2X revenue and 3X profit growth seems far from reach. In order to achieve this current FY revenue growth needs to be 25% then 60% in next year.
- 70% payment done by government, even though the receivable days were lower in previous quarter. This is big risk that payment gets delayed.
- No bargain power in quoting project (even in re-tendering, recent example Assam where they quoted below the previous quoted price)
- Project getting delayed, can be seen in current to previous investor presentation.
Tracking.
Disc:Was invested, no position now.
Subscribe To Our Free Newsletter |